Incyte INCY
NASDAQ INCY
$126.75 -1.25 (-0.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Incyte (INCY) Change in Cash (2010 - 2026)

Incyte's (INCY) quarterly Change in Cash came in at $521.2 million in Q2 2026, up 3782.33% YoY from $13.4 million in Q2 2025, and up 43.48% on a QoQ basis from $363.3 million in Q1 2026.

Analysis

Incyte (INCY) Change in Cash (2010 - 2026) Analysis & Trends

Incyte (INCY) has 17 years of Change in Cash data on file, last reported at $521.2 million in Q2 2026.

  • Quarterly Change in Cash rose 3782.33% year-over-year to $521.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 billion (up 109.46% YoY) and the FY2025 annual result came in at $1.4 billion, up 192.43% from the prior year.
  • Change in Cash improved to $521.2 million in Q2 2026, from $363.3 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $642.8 million in Q4 2025 to a low of -$2.4 billion in Q2 2024.
  • A 5-year average of $106.9 million and a median of $254.6 million in 2022 frame the typical range for Change in Cash.
  • Annual changes were most pronounced in 2024 — Change in Cash plunged 860.76% — and 2026, when it surged 3782.33%.
  • Tracing INCY's Change in Cash over 5 years: stood at $260.9 million in 2022, then slumped by 105.26% to -$13.7 million in 2023, then surged by 2894.73% to $383.6 million in 2024, then jumped by 67.57% to $642.8 million in 2025, then retreated by 18.91% to $521.2 million in 2026.
  • The last three Change in Cash figures came in at $521.2 million (Q2 2026), $363.3 million (Q1 2026), and $642.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 521.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 521.24 Mn
Mar 31, 2026 363.28 Mn
Dec 31, 2025 642.82 Mn
Sep 30, 2025 500.04 Mn
Jun 30, 2025 13.43 Mn
Mar 31, 2025 253.94 Mn
Dec 31, 2024 383.61 Mn
Sep 30, 2024 316.92 Mn
Jun 30, 2024 -2.36 Bn
Mar 31, 2024 132.61 Mn
Dec 31, 2023 -13.73 Mn
Sep 30, 2023 96.11 Mn
Jun 30, 2023 310.07 Mn
Mar 31, 2023 -130.35 Mn
Dec 31, 2022 260.90 Mn
Sep 30, 2022 255.20 Mn
Jun 30, 2022 178.57 Mn
Mar 31, 2022 199.30 Mn
Dec 31, 2021 58.46 Mn
Sep 30, 2021 201.44 Mn